| 1 |
Interferon-gamma effect on ...
|
Mus musculus
|
Mus musculus |
|
| 2 |
Comparison of bone marrow-derived macrophages ...
|
Mus musculus
|
Mus musculus |
| Cell |
Macrophages |
| Perturbation |
INFgamma |
| Disease |
BALB/c BMM |
|
| 3 |
Comparison of bone marrow-derived macrophages ...
|
Mus musculus
|
Mus musculus |
| Cell |
Macrophages |
| Perturbation |
INFgamma |
| Disease |
C57Bl6 BMM |
|
| 4 |
Gene expression profile of human epidermal ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Keratinocytes |
| Perturbation |
IFNgamma |
|
| 5 |
Contribution of the STAT1alpha and STAT1beta ...
|
Mus musculus
|
Mus musculus |
| Cell |
Macrophages |
| Perturbation |
IFNgamma |
| Disease |
BMM macrophages - 24h ... |
|
| 6 |
Bone marrow macrophage (BMMF) response to ...
|
Mus musculus
|
Mus musculus |
| Cell |
Macrophages |
| Perturbation |
IFNgamma |
| Disease |
Bone marrow macrophage |
|
| 7 |
Contribution of the STAT1alpha and STAT1beta ...
|
Mus musculus
|
Mus musculus |
| Cell |
Macrophages |
| Perturbation |
IFNgamma |
| Disease |
BMM macrophages - 6h IFNg |
|
| 8 |
TPL-2;ERK1/2 signaling promotes host ...
|
Mus musculus
|
Mus musculus |
| Cell |
Macrophages |
| Perturbation |
INFgamma |
| Disease |
Bone marrow derived ... |
|
| 9 |
TPL-2;ERK1/2 signaling promotes host ...
|
Mus musculus
|
Mus musculus |
| Cell |
Macrophages |
| Perturbation |
INFgamma |
| Disease |
Bone marrow derived ... |
|
| 10 |
Defining precision probes which differentiate ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Submandibular gland |
| Disease |
IFNgamma - 4hr - 50ng/ml |
| Disease |
HSG submandibular ... |
|
| 11 |
Distinct roles for IL-27 and IFN-g in the ...
|
Mus musculus
|
Mus musculus |
| Cell |
iTreg |
| Disease |
10 hrs |
|
| 12 |
Defining precision probes which differentiate ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Submandibular gland |
| Disease |
IFNgamma - 12hr - 50ng/ml |
| Disease |
HSG submandibular ... |
|
| 13 |
Distinct roles for IL-27 and IFN-g in the ...
|
Mus musculus
|
Mus musculus |
| Cell |
iTreg |
| Disease |
48 hrs |
|
| 14 |
Defining precision probes which differentiate ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Submandibular gland |
| Disease |
IFNgamma - 24hr - 50ng/ml |
| Disease |
HSG submandibular ... |
|
| 15 |
Defining precision probes which differentiate ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Submandibular gland |
| Disease |
IFNgamma - 48hr - 50ng/ml |
| Disease |
HSG submandibular ... |
|
| 16 |
Expression profiling in Wild-type and C-JUN ...
|
Mus musculus
|
Mus musculus |
| Cell |
Embryonic fibroblast |
| Perturbation |
IFNgamma |
|
| 17 |
Gene expression profiling of primary human ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Hepatocytes |
| Perturbation |
IFNgamma |
| Disease |
Primary human ... |
|
| 18 |
IFN-gamma activation of cultured neonatal rat ...
|
Rattus norvegicus
|
Rattus norvegicus |
| Cell |
Microglia |
| Perturbation |
IFNgamma |
|
| 19 |
TPL-2;ERK1/2 signaling promotes host ...
|
Mus musculus
|
Mus musculus |
| Cell |
Macrophages |
| Disease |
1 hr |
|
| 20 |
TPL-2;ERK1/2 signaling promotes host ...
|
Mus musculus
|
Mus musculus |
| Cell |
Macrophages |
| Disease |
6 hr |
|
| 21 |
Gene expression profiling of primary human ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Hepatocytes |
| Perturbation |
IFNgamma |
| Disease |
Primary human ... |
|
| 22 |
TCL001: Calu-3 cells treated with either IFN ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Calu3 cells |
| Perturbation |
IFNgamma |
| Disease |
6 hrs |
|
| 23 |
TCL001: Calu-3 cells treated with either IFN ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Calu3 cells |
| Perturbation |
IFNgamma |
| Disease |
3 hrs |
|
| 24 |
TCL001: Calu-3 cells treated with either IFN ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Calu3 cells |
| Perturbation |
IFNgamma |
| Disease |
21 hrs |
|
| 25 |
Gene expression analysis of macrophages from ...
|
Homo sapiens
|
Homo sapiens |
| Cell |
Macrophages |
| Perturbation |
IFNgamma |
|
| 26 |
STAT1 independent control of a neurotropic ...
|
Mus musculus
|
Mus musculus |
| Cell |
Neuron |
| Perturbation |
IFNgamma |
| Disease |
3 hrs - primary ... |
|
| 27 |
STAT1 independent control of a neurotropic ...
|
Mus musculus
|
Mus musculus |
| Cell |
Neuron |
| Perturbation |
IFNgamma |
| Disease |
6 hrs - primary ... |
|
| 28 |
STAT1 independent control of a neurotropic ...
|
Mus musculus
|
Mus musculus |
| Cell |
Neuron |
| Perturbation |
IFNgamma |
| Disease |
24 hrs - primary ... |
|